Eiko Lifesciences acquires 25.01% stake in Reflux Pharmaceuticals ...Middle East

Business Standard - Economy
The acquisition is part of ELL's long-term strategic growth plan to diversify its portfolio and enter new markets

Hence then, the article about eiko lifesciences acquires 25 01 stake in reflux pharmaceuticals was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Eiko Lifesciences acquires 25.01% stake in Reflux Pharmaceuticals )

Apple Storegoogle play

Last updated :

Also on site :



Latest News